Intermittent Fasting for Aging, Wellness & Longevity

The concept of fasting for spiritual & cultural reasons are undertaken as part of religious activities across the world by followers of many religions.  More recently, fasting has been demonstrated to be associated with significant health benefits including influencing aging and healthspan.  Intermittent fasting (IF) refers to an eating pattern where individuals cycle between periods of eating and fasting.  Instead of focusing on what you eat, it emphasizes when you eat.  The idea behind intermittent fasting is that it gives your body time to process food more efficiently, leading to various health benefits.  Potential benefits of intermittent fasting include weight loss, improved metabolism, and better blood sugar control.

Clinical Summary (Dr. Kastoori Iyengar, MD. MBA.)

Although the science underlying benefits of fasting (initially focused on caloric restriction, CR) has been demonstrated in numerous cellular and animal models, there is a growing number of experimental studies and randomized clinical trials suggesting that the amount and timing of food intake as well as the daily time window during which food is consumed, are crucial determinants of cardiovascular and cognitive health.   Recently, different forms of fasting have become an increasingly attractive strategy to directly address aging, improve healthspan and potentially limit or delay the onset of aging related disorders including cardiovascular, metabolic and neurological diseases.

Intermittent fasting (IF) is a pattern of eating that alternate between periods of eating and fasting.  It involves cycling between periods of eating and fasting, typically through methods like (that are popular):

  • 16/8 method (16 hours of fasting, 8-hour eating window)

  • 5:2 approach (5 normal eating days, 2 non-consecutive days of restricted calories)

  • 24-hour fasts once or twice per week

Caloric restriction, on the other hand, involves reducing daily caloric intake by about 20-40% while maintaining proper nutrition. While different in approach, both IF and CR trigger similar cellular and metabolic responses in our bodies.

Clinical evidence suggests that intermittent fasting may confer several health benefits, including weight loss and improved insulin sensitivity, potentially reducing the risk of type 2 diabetes. It may also enhance lipid profiles and reduce markers of inflammation, thus lowering the risk of cardiovascular disease. Additionally, IF has been shown to stimulate autophagy, a process of cellular repair, and may have neuroprotective effects by increasing brain-derived neurotrophic factor (BDNF). Some studies also suggest a potential role in promoting longevity through mechanisms similar to those seen with caloric restriction. However, more research is needed, and caution is advised for individuals with pre-existing medical conditions or those at risk of nutritional deficiencies.

Clinical Benefits In Randomized Controlled Clinical Trails

·        Weight loss: Intermittent fasting increased weight loss compared to eating over 12 hours or more throughout the day

·        Improved blood pressure: Time-restricted eating improved diastolic blood pressure

  • Enhanced mood: Participants reported improved mood with intermittent fasting

  • Better glucose tolerance: Intermittent fasting led to greater improvements in postprandial glucose metabolism in adults at increased risk of developing type 2 diabetes

  • Reduced insulin resistance: Intermittent fasting significantly improved the homeostatic model assessment of insulin resistance (HOMA-IR)

  • Improved Metabolic Syndrome Score: Participants following intermittent fasting showed a significant improvement in their Metabolic Syndrome Score

  • Glycemic control: A 5:2 intermittent fasting meal replacement approach achieved better glycemic control compared to metformin and empagliflozin in adults with type 2 diabetes

  • ·        Reduced body mass index (BMI): Modified alternate-day fasting was associated with a moderate reduction in BMI in adults with overweight or obesity

  • Improved cardiometabolic risk factors: Intermittent fasting showed benefits for various cardiometabolic risk factors in adults with overweight or obesity

  • It's important to note that while these benefits have been observed in clinical trials, some studies have shown mixed results or no significant improvements in certain health markers. More research is needed to fully understand the long-term effects and optimal protocols for intermittent fasting

The Science Underlying Intermittent Fasting in Aging, Wellness & Longevity (Rangaprasad Sarangarajan, Ph.D.)

Intermittent fasting (IF) has been associated with mechanisms that may slow aging and improve longevity, largely based on studies in animal models and emerging evidence in humans. IF appears to mimic the effects of caloric restriction, which has been extensively studied for its role in extending lifespan across various species. Caloric restriction and IF both activate several cellular pathways related to stress resistance and metabolic efficiency, particularly the mammalian target of rapamycin (mTOR) pathway and sirtuins, which play roles in cellular repair and longevity.  It may also promote cellular repair and reduce inflammation, which is linked to chronic diseases like heart disease and diabetes. IF can also improve brain health by boosting brain-derived neurotrophic factor (BDNF), which supports brain function.

Evidence from animal studies demonstrates that intermittent fasting can increase lifespan by improving mitochondrial function, reducing oxidative stress, and enhancing autophagy—a process where cells remove damaged components, thereby reducing the accumulation of cellular damage, a key factor in aging. In one notable study, mice subjected to intermittent fasting lived up to 30% longer than their counterparts on normal diets, with improvements in metabolic health and reductions in age-related diseases, such as cancer and neurodegenerative disorders.

Several biological mechanisms have been attributed to intermittent fasting associated benefits for aging, longevity and wellness.  These include:

Adaptive Stress Response: During the fasting times, the cells in our body experiences a mild form of stress known as adaptive stress. This triggers the body to active protective mechanisms, that over time makes the cells resilient. The cells achieve resilience by

  • Increasing production of antioxidants protecting the cells from damage

  • Increases the processes influencing DNA repair (i.e. potentially lowers the risk of spontaneous mutations or damage to DNA)

  • Promotes the cells ability to clean itself, removing the damaged components by the process of autophagy

  • Reduce inflammation throughout the body

Metabolic Pathways:  Intermittent fasting influences major metabolic pathways influencing cells ability to use energy (bio-energetics).  These include improvements in insulin sensitivity and signaling for better management of blood glucose levels, activating the mTOR pathway for supporting proper growth related signaling, activation of AMPK (a key regulator of energy metabolism & utilization) by increasing burning of fat and increase activity of sirtuins (family of proteins associated with longevity) to improve overall cellular health.

While long-term human studies are limited, early clinical trials suggest intermittent fasting may improve biomarkers associated with aging, such as insulin sensitivity, inflammatory markers, and cholesterol profiles, potentially contributing to healthier aging.

References

  • Jamshed H, Steger FL, Bryan DR, et al. Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial. JAMA Intern Med. 2022;182(9):953–962. doi:10.1001/jamainternmed.2022.3050

  • Teong, X.T., Liu, K., Vincent, A.D. et al. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial. Nat Med 29, 963–972 (2023). https://doi.org/10.1038/s41591-023-02287-7

  • Patterson RE, Laughlin GA, LaCroix AZ, Hartman SJ, Natarajan L, Senger CM, Martínez ME, Villaseñor A, Sears DD, Marinac CR, Gallo LC. Intermittent Fasting and Human Metabolic Health. J Acad Nutr Diet. 2015 Aug;115(8):1203-12. doi: 10.1016/j.jand.2015.02.018. Epub 2015 Apr 6. PMID: 25857868; PMCID: PMC4516560.

  • Ciera L Bartholomew, Joseph B Muhlestein, Heidi T May, Viet T Le, Oxana Galenko, Kelly Davis Garrett, Cherie Brunker, Ramona O Hopkins, John F Carlquist, Kirk U Knowlton, Jeffrey L Anderson, Bruce W Bailey, Benjamin D Horne, Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial, European Heart Journal Open, Volume 1, Issue 2, September 2021, oeab026, https://doi.org/10.1093/ehjopen/oeab026

  • Guo L, Xi Y, Jin W, et al. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes: The EARLY Randomized Clinical Trial. JAMA Netw Open. 2024;7(6):e2416786. doi:10.1001/jamanetworkopen.2024.16786

  • Morales-Suarez-Varela M, Collado Sánchez E, Peraita-Costa I, Llopis-Morales A, Soriano JM. Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials. Nutrients. 2021 Sep 13;13(9):3179. doi: 10.3390/nu13093179. PMID: 34579056; PMCID: PMC8469355.

  • El-Outa A, Ghandour L, Hamade H, Borgi C, Fares EJ, Gherbal T, Mufarrij A. Intermittent fasting & performance: The iFast clinical trial protocol. Contemp Clin Trials Commun. 2021 Apr 15;25:100766. doi: 10.1016/j.conctc.2021.100766. PMID: 35024492; PMCID: PMC8728049.

  • Patikorn C, Roubal K, Veettil SK, et al. Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. JAMA Netw Open. 2021;4(12):e2139558. doi:10.1001/jamanetworkopen.2021.39558

  • De Cabo, R., & Mattson, M. P. (2019). Effects of intermittent fasting on health, aging, and disease. New England Journal of Medicine, 381(26), 2541-2551.
    DOI: 10.1056/NEJMra1905136.

  • Catterson, J. H., Khericha, M., Dyson, M. C., Vincent, A. J., Callard, R., Haveron, S. M., Rajasingam, A., Ahmad, M., & Partridge, L. (2018). Short-term fasting alters the gut microbiome in a manner that protects against diet-induced obesity. Nature Communications, 9(1), 4645.
    DOI: 10.1038/s41467-018-06843-3

  • Zhang, C., Yin, A., Li, H., Wang, R., Wu, G., Shen, J., Zhang, M., Wang, J., & Zhao, L. (2015). Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine, 2(8), 968-984. DOI: 10.1016/j.ebiom.2015.07.007

  • Patterson, R. E., Laughlin, G. A., LaCroix, A. Z., Hartman, S. J., Natarajan, L., Senger, C. M., Martínez, M. E., & Villaseñor, A. (2015). Intermittent fasting and human metabolic health. Journal of the Academy of Nutrition and Dietetics, 115(8), 1203-1212. DOI: 10.1016/j.jand.2015.02.018

  • Maci, M. M., González-Hernández, M. A., González-Molero, I., Ruiz-Gutiérrez, V., & Delgado-Alonso, C. (2020). Influence of intermittent fasting on gut microbiota composition and metabolic health: a systematic review. Nutrients, 12(12), 3770. DOI: 10.3390/nu12123770

  • Arumugam TV, Alli-Shaik A, Liehn EA et al.  Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting  eLife 12:RP89214.  https://doi.org/10.7554/eLife.89214.2

  • Di Francesco, A., Deighan, A.G., Litichevskiy, L. et al. Dietary restriction impacts health and lifespan of genetically diverse mice. Nature 634, 684–692 (2024). https://doi.org/10.1038/s41586-024-08026-3

  • Longo VD, Mattson MP.  Fasting: Molecular mechanisms and clinical applications. Cell Metabolism. 19(2):181-192 (2014) https://doi.org/10.1016/j.cmet.2013.12.008

  • Vo N, Zhang Q, Sung HK. From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling. J Pharm Pharm Sci. 2024 Jul 22;27:13062. doi: 10.3389/jpps.2024.13062. PMID: 39104461; PMCID: PMC11298356.